Chloe Cole, a prominent detransitioner advocate, sees a recent $2 million malpractice settlement in New York as a pivotal precedent, predicting a wave of similar lawsuits from young people who regret gender transition procedures.
Eldorado Gold is set to acquire Foran Mining in an all-stock transaction valued at C$3.8 billion, aiming to create a diversified gold and copper producer with two flagship projects slated to begin production in 2026, significantly boosting its output and cash flow profile.
Amidst record market levels, analysts highlight a select group of companies—from AI leaders to emerging fintech—with strong fundamentals and room for significant expansion.
Despite a respectable return on capital, Coles Group's flat performance over five years signals a mature business in a holding pattern, leading investors to question its long-term compounding potential.
A notable easing of US-Iran tensions has buoyed investor confidence across Gulf bourses, creating a favorable backdrop for stable, income-generating equities. We analyze three regional dividend stocks offering potential portfolio resilience amid shifting market dynamics.
Industrial battery giant EnerSys (ENS) is set to report its fiscal fourth-quarter results after Wednesday's market close. Investors are weighing strong recent performance against a history of revenue misses and a tempered growth outlook.
Payment technology firm WEX Inc. is set to release its quarterly financial results after Wednesday's market close, with Wall Street anticipating a return to revenue growth following last year's dip.
Samsung Electronics unveils enhanced privacy controls for Galaxy devices and a special Olympic Edition of its foldable phone, aiming to bolster its brand in security and high-profile partnerships while its shares show significant long-term gains.
Werner Enterprises sees its fair value estimate raised significantly amid shifting analyst sentiment, driven by expectations of tighter truckload capacity and a potential freight market recovery.
GE HealthCare Technologies prepares to release its fourth-quarter financial results amid steady analyst expectations and a mixed performance landscape for medical equipment peers.
Old Dominion Freight Line prepares to release its quarterly results Wednesday morning, with analysts projecting a revenue dip but watching for signs of resilience in a challenging transport market.
Monarch Casinos & Resorts (MCRI) will release its fourth-quarter financial results after Wednesday's market close, with analysts projecting modest revenue growth but heightened scrutiny on its high-end gaming segment performance.
Bio-Techne prepares to report quarterly earnings against a backdrop of declining revenue projections and mixed performances from life sciences peers.
Fox Corporation (NASDAQ: FOXA) is scheduled to release its fourth-quarter financial results Wednesday morning, with analysts anticipating steady revenue but slower growth compared to last year's surge.
Food distribution leader Performance Food Group (NYSE: PFGC) is scheduled to release its quarterly earnings before markets open on Wednesday, with analysts projecting moderated revenue growth and continued pressure on profitability.
Amidst a market often swayed by speculative narratives, Zetrix AI Berhad (KLSE:ZETRIX) stands out with a track record of robust earnings growth and strong insider alignment, offering a compelling case for fundamentals-focused investors.
Western wear retailer Boot Barn (NYSE: BOOT) is scheduled to release its fourth-quarter financial results after market close this Wednesday, with investors keenly watching for signs of sustained growth in a competitive apparel landscape.
After Abbott Laboratories' stock plunged nearly 10% on disappointing revenue, CEO Robert B. Ford made a significant personal investment, purchasing $2 million in company shares. This move, seen as a strong signal of insider confidence, highlights a clash between short-term market jitters and long-term corporate strategy.
Amid forecasts of rising economic stress and market volatility in 2026, investment bank Houlihan Lokey (NYSE: HLI) is attracting bullish attention for its dual strength in M&A advisory and corporate restructuring. Analysts point to its defensive positioning and potential to capture outsized gains in a shifting financial landscape.
A sophisticated, high-conviction options trade by a large investor signals strong confidence in Edwards Lifesciences' fundamentals, with a potential breakout eyed for early 2026 tied to regulatory milestones and sustained growth in its mitral valve business.
